Medical Property Trust (MPW) owns real estate and hospital buildings in 9 countries primarily in the US and Europe. It has 435 properties, 42,000 licensed beds, and operated by 53 different operating tenants. MPW allowed the unethical Steward Health Care…
The dawn of the next industrial revolution is upon us, and its driving force is none other than Artificial Intelligence (AI). This transformative technology is reshaping industries, creating unprecedented opportunities, and redefining what is possible. This is an undeniable fact…
I’ve been diving into MDA Space lately, and I think they might be one of the best-kept secrets in the market right now. If you haven’t heard of them yet, here’s a quick rundown on why I think they’re undervalued…
Monster (MNST) is currently undervalued. This past week, the company announced its Q2 report, which fell short of analyst expectations. As a result, the stock dropped 7% since the announcement. Combined with a 20% drop over the past year-to-date, the…
American lidar technology startup Ouster, Inc. (OUST) has its main office in San Francisco, California. It creates digital, high-resolution 3D lidar sensors for industrial, robotics, autonomous vehicles, drones, mapping, defense, and security applications. What is Lidar? Why OUST’s variant of…
Recursion Pharmaceuticals (RXRX) is making waves in the biotech sector, driven by a robust drug pipeline and strategic acquisitions that position the company as a leader in AI-driven drug discovery. This analysis explores the key factors that make RXRX a…
The market is sleeping on this one. Pitney Bowes is primed for a massive turnaround with potential to sky rocket in the short term and triple in value over the next 2 years. I’m betting on them with shares, short…
Landbridge recently IPO’d on June 28th and I think their business model presents an interesting growth opportunity. So who are they? Founded in 2021, Landbridge owns about 220,000 acres of land across Texas and New Mexico in the Permian Basin…
“Risk can not be eliminated. It can only be shifted in time and redistributed in form” -Chris Chole (Artemis Capital) Gold and Silver troughed and washed out hard in Q3 2022. Since that point in time a group of senior…
Just to be clear this is not financial advice, and there are more factors than an earnings beat that affect stock price, but this is why I think NVDA will beat revenue predictions of $28B on Aug 28th 2024. As…